Logo image of ACCS

ACCESS NEWSWIRE INC (ACCS) Stock Fundamental Analysis

NYSEARCA:ACCS - NYSE Arca - US46520M2044 - Common Stock - Currency: USD

12.25  +0.64 (+5.51%)

Fundamental Rating

3

Taking everything into account, ACCS scores 3 out of 10 in our fundamental rating. ACCS was compared to 283 industry peers in the Software industry. Both the profitability and financial health of ACCS have multiple concerns. ACCS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ACCS had positive earnings in the past year.
ACCS had a positive operating cash flow in the past year.
Of the past 5 years ACCS 4 years were profitable.
Each year in the past 5 years ACCS had a positive operating cash flow.
ACCS Yearly Net Income VS EBIT VS OCF VS FCFACCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ACCS has a Return On Assets (-11.14%) which is in line with its industry peers.
With a Return On Equity value of -17.05%, ACCS perfoms like the industry average, outperforming 44.33% of the companies in the same industry.
Industry RankSector Rank
ROA -11.14%
ROE -17.05%
ROIC N/A
ROA(3y)-5.74%
ROA(5y)-0.56%
ROE(3y)-11.6%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
ACCS Yearly ROA, ROE, ROICACCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

ACCS's Gross Margin of 77.19% is fine compared to the rest of the industry. ACCS outperforms 74.11% of its industry peers.
In the last couple of years the Gross Margin of ACCS has grown nicely.
ACCS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y1.91%
ACCS Yearly Profit, Operating, Gross MarginsACCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

3

2. Health

2.1 Basic Checks

ACCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACCS has been increased compared to 1 year ago.
Compared to 5 years ago, ACCS has more shares outstanding
The debt/assets ratio for ACCS is higher compared to a year ago.
ACCS Yearly Shares OutstandingACCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ACCS Yearly Total Debt VS Total AssetsACCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 2.01 indicates that ACCS is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACCS's Altman-Z score of 2.01 is in line compared to the rest of the industry. ACCS outperforms 51.06% of its industry peers.
ACCS has a debt to FCF ratio of 1.26. This is a very positive value and a sign of high solvency as it would only need 1.26 years to pay back of all of its debts.
The Debt to FCF ratio of ACCS (1.26) is better than 73.05% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that ACCS is not too dependend on debt financing.
ACCS's Debt to Equity ratio of 0.10 is in line compared to the rest of the industry. ACCS outperforms 52.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.26
Altman-Z 2.01
ROIC/WACCN/A
WACC10.8%
ACCS Yearly LT Debt VS Equity VS FCFACCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.75 indicates that ACCS may have some problems paying its short term obligations.
The Current ratio of ACCS (0.75) is worse than 82.98% of its industry peers.
ACCS has a Quick Ratio of 0.75. This is a bad value and indicates that ACCS is not financially healthy enough and could expect problems in meeting its short term obligations.
ACCS has a worse Quick ratio (0.75) than 82.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
ACCS Yearly Current Assets VS Current LiabilitesACCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

ACCS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.89%.
ACCS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.60% yearly.
The Revenue for ACCS has decreased by -32.00% in the past year. This is quite bad
The Revenue has been growing slightly by 7.19% on average over the past years.
EPS 1Y (TTM)-36.89%
EPS 3Y-10.86%
EPS 5Y9.6%
EPS Q2Q%-37.5%
Revenue 1Y (TTM)-32%
Revenue growth 3Y1.76%
Revenue growth 5Y7.19%
Sales Q2Q%-21.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to decrease by -3.65% on average over the next years.
EPS Next Y5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.61%
Revenue Next 2Y-3.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACCS Yearly Revenue VS EstimatesACCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ACCS Yearly EPS VS EstimatesACCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.85, which indicates a rather expensive current valuation of ACCS.
Based on the Price/Earnings ratio, ACCS is valued cheaply inside the industry as 80.50% of the companies are valued more expensively.
ACCS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.48.
Based on the Price/Forward Earnings ratio of 17.16, the valuation of ACCS can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACCS indicates a rather cheap valuation: ACCS is cheaper than 83.33% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.04. ACCS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.85
Fwd PE 17.16
ACCS Price Earnings VS Forward Price EarningsACCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACCS.
Based on the Price/Free Cash Flow ratio, ACCS is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.63
EV/EBITDA 404.95
ACCS Per share dataACCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.77
PEG (5Y)1.96
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACCS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACCESS NEWSWIRE INC

NYSEARCA:ACCS (8/8/2025, 8:17:52 PM)

12.25

+0.64 (+5.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-12 2025-08-12/bmo
Inst Owners41.8%
Inst Owner ChangeN/A
Ins Owners22.46%
Ins Owner Change2.79%
Market Cap47.16M
Analysts82.5
Price Target15.3 (24.9%)
Short Float %0.06%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.39%
Min EPS beat(2)-62.29%
Max EPS beat(2)-10.49%
EPS beat(4)1
Avg EPS beat(4)-21.68%
Min EPS beat(4)-62.29%
Max EPS beat(4)2.71%
EPS beat(8)2
Avg EPS beat(8)-25.47%
EPS beat(12)4
Avg EPS beat(12)-18.9%
EPS beat(16)6
Avg EPS beat(16)-9.39%
Revenue beat(2)0
Avg Revenue beat(2)-15.89%
Min Revenue beat(2)-22.56%
Max Revenue beat(2)-9.23%
Revenue beat(4)0
Avg Revenue beat(4)-9.35%
Min Revenue beat(4)-22.56%
Max Revenue beat(4)-1.08%
Revenue beat(8)0
Avg Revenue beat(8)-11.65%
Revenue beat(12)1
Avg Revenue beat(12)-9.09%
Revenue beat(16)3
Avg Revenue beat(16)-6.54%
PT rev (1m)0%
PT rev (3m)15.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-61.36%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.02%
Revenue NY rev (1m)-4.29%
Revenue NY rev (3m)-4.29%
Valuation
Industry RankSector Rank
PE 18.85
Fwd PE 17.16
P/S 2.19
P/FCF 18.63
P/OCF 16.15
P/B 1.53
P/tB N/A
EV/EBITDA 404.95
EPS(TTM)0.65
EY5.31%
EPS(NY)0.71
Fwd EY5.83%
FCF(TTM)0.66
FCFY5.37%
OCF(TTM)0.76
OCFY6.19%
SpS5.6
BVpS8.02
TBVpS-0.1
PEG (NY)3.77
PEG (5Y)1.96
Profitability
Industry RankSector Rank
ROA -11.14%
ROE -17.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.19%
FCFM 11.73%
ROA(3y)-5.74%
ROA(5y)-0.56%
ROE(3y)-11.6%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y1.91%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.26
Debt/EBITDA 30.15
Cap/Depr 13.45%
Cap/Sales 1.81%
Interest Coverage N/A
Cash Conversion 2755.66%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 2.01
F-Score4
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)14.81%
Cap/Depr(5y)14.14%
Cap/Sales(3y)1.67%
Cap/Sales(5y)1.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.89%
EPS 3Y-10.86%
EPS 5Y9.6%
EPS Q2Q%-37.5%
EPS Next Y5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32%
Revenue growth 3Y1.76%
Revenue growth 5Y7.19%
Sales Q2Q%-21.34%
Revenue Next Year-19.61%
Revenue Next 2Y-3.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-227.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year244.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.46%
FCF growth 3Y-17.03%
FCF growth 5Y0.97%
OCF growth 1Y-21.96%
OCF growth 3Y-12.59%
OCF growth 5Y1.99%